US visitors, please note: This website contains information on the PROGENSA® PCA3 Assay which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or applicable in the USA. View details on US FDA approval for PROGENSA® PCA3 Assay.
Additional (often hormone) treatment given before the primary treatment (radiotherapy or radical prostatectomy) to increase the effect of the treatment/chance of a cure